Incidental focal 18F-FDG uptake in the pituitary gland: clinical significance and differential diagnostic criteria.
retrospective_cohort · Level III
Where this comes from
- Record sourced from PubMed, PMID 21421711.
- Also identified by DOI 10.2967/jnumed.110.083733.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
The purpose of this study was to identify the incidence and clinical significance of incidental pituitary uptake on whole-body (18)F-FDG PET/CT. We evaluated 13,145 consecutive subjects who underwent (18)F-FDG PET/CT. The final diagnosis of pathologic or physiologic uptake was based on brain MRI and follow-up PET scanning. Receiver-operating-characteristic curve analysis was performed to determine an optimal cutoff for detecting pathologic uptake. We found that 107 (0.8%) subjects showed incidental pituitary uptake. In 29 of 71 subjects with the final diagnosis, the pituitary uptake was pathologic: macroadenomas (n = 21), microadenomas (n = 5), and malignancy (n = 3). When a maximum standardized uptake value of 4.1 was used as an optimal criterion for detecting pathologic uptake, the diagnostic sensitivity, specificity, and accuracy were 96.6%, 88.1%, and 91.5%, respectively. Although incidental pituitary uptake is an unusual finding, the degree of (18)F-FDG accumulation is helpful in identifying pathologic pituitary lesions that warrant further diagnostic evaluation.
Medical subject headings
- Fluorodeoxyglucose F18
- Pituitary Gland
- Pituitary Neoplasms
- Radiopharmaceuticals